denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Sanofi
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Clinical trials, Combination therapy, Antibody Therapy, Clinical Practice (Health Services and Quality), Clinical Research, Diversity, Equity, and Inclusion (DEI), Diseases, Treatment Considerations, Biological therapies, Immunotherapy, Adverse Events, Monoclonal Antibody Therapy
Hematology Disease Topics & Pathways:
Research, Clinical trials, Combination therapy, Antibody Therapy, Clinical Practice (Health Services and Quality), Clinical Research, Diversity, Equity, and Inclusion (DEI), Diseases, Treatment Considerations, Biological therapies, Immunotherapy, Adverse Events, Monoclonal Antibody Therapy
Friday, December 6, 2024: 11:00 AM-2:00 PM
Room 6B
(San Diego Convention Center)
Chair:
Thomas G. Martin, MD, Professor University of California, San Francisco, Associate Chief, Hematology/Oncology
Disclosures:
Martin: Poseida: Research Funding; Sanofi: Research Funding; Janssen: Research Funding; BMS: Research Funding; GSK, Pfizer, Roche: Honoraria.
Speakers:
Carlyn Rose Tan, MD, Memorial Sloan Kettering Cancer Center
and
Kenneth Capps, JD, Patient Advocate
Disclosures:
Tan: Takeda: Research Funding; Sanofi: Honoraria; Janssen: Honoraria, Research Funding.
They've become a game-changer in early relapse multiple myeloma: anti-CD38–based triplet regimens. These therapies have the potential to improve outcomes AND optimize quality of life. But do you know how to incorporate performance status, relapse aggressiveness, cytogenetics, and other patient-centered factors to tailor your treatment approach? Two myeloma experts will spend 60 minutes in a lively discussion and case-based debate on the latest updates in anti-CD38–based triplets for relapsed/refractory myeloma. They will also discuss best practices to promote diversity, equity, and inclusion in myeloma care. Then, a patient will join the experts to recount the highs and lows of their journey living with myeloma, and how their mindset prepared them for their fight against cancer.
Join our closing live Q&A to challenge our experts and enhance your understanding of these therapies. Connect with experts, stay informed, and be part of the RRMM care revolution!
See more of: Friday Satellite Symposia